One of the first actions of the new Trump administration was I will withdraw from the World Health Organization. Many public health advocates quickly raised the alarm bell, citing years of debate about the importance of the agency and how the US stood to lose by withdrawing membership and money.
These supporters have rarely paused to consider years of reform efforts to be a necessary disruption after a long story but short outcome. One of us knew this firsthand and worked within WHO at the highest level. The other sees this as a private sector innovator trying to navigate the bureaucratic maze.
The WHO was created in 1948. “Achievement by all people at the highest possible health level” And to deal with the spread of infectious disease outbreaks in countries. It was important for both the US leadership at the time and for decades, both for the WHO and its financial science.
The US is currently contributing It's just over 1 billion dollars and the largest national donor to the WHO budget. But the problem is not money, it's just something .06% of the US government budget. The problem is the organization.
At some point in its history, WHO was the true North star of the world for infectious diseases and promotion of health. Sadly, organizations are exacerbated in both management effectiveness and scientific expertise, making them inefficient and confusing.
During Covid, when the world needed it most, WHO failed at many levels. The delay delay that declares COVID to be an airborne virus remains a surprising uncorrected error. Meanwhile, the central bureaucratic process of WHO and Covax (a Geneva-based coalition launched by WHO to “coordinate” community responses between agencies) often hampered rather than supporting effective responses at the regional and national level.
Even those who acknowledge that limitation often say that WHO needs our support. Because it serves an important function in medicines and vaccines that promote the benefits of the American private sector. Or, they say, without US funding, as long as the US looks out, if there is an opportunity for reform, they will be ruled by American enemies.
In fact, reality is completely the opposite. No one's function determines the success or failure of the American private sector. Slow process and heavy bureaucracy when working with the private sector Framework for engagement with non-state actors In many cases, agents are a barrier to saving American health products. And with regard to the presumed US enemy, concerns have existed over the years of full US funding.
Who was reform the theme? Despite recent claims from last month, despite recent claims based on who the organization has, it still remains for the past 20 years in the US “It's completely reformed” There are serious human resources issues, and even unique reform efforts (from strengthening country offices) Addressing harassment after UNS' biggest sexual abuse scandal) Maintain ongoing problems.
The US government is gaining value from its relationship with WHO. Nevertheless, it is a too-large price, too-low returns, too-slow pace. Yes, being voided over time to global health will hurt America's interests, but as usual, continuous business will hurt America and the world much more in the coming years.
For those who have committed to serving the global health mission, engagement rather than hand-wrapping is the best strategy. What does this look like?
First, we will see that an announcement of withdrawal from who will bring about change. Leaves must not be binary. They are completely involved or nothing. To make this presentation issue means to commence negotiations for a global health architecture remodel.
This year's key funding conference is taking place for not only WHO but all major “Global Health Initiatives,” including global funds that provide funding and leadership in the fight against HIV, tuberculosis and malaria. Take advantage of the withdrawal notice period – ultimately for a long time – negotiate targeted roles for other institutions in the wake of being pulled back from the smartest Americans.
Second, look for immediate and better solutions to prepare the US for the next pandemic. Past experiences with Covid-19, Ebola and MPOX have taught us that relying on public organizations with time-limited funds is always a losing battle. Investment and lessons learned Operation warp speed It has laid the foundation for a smarter approach to pandemic response. This allows private organizations to help sustain both non-urgent global health needs and outbreak roles.
Finally, we will work with other countries to recreate a global health organization that is worthy of our purpose. The argument was always that no matter who you start to tear apart, it would look like it is today. This is not true. With a strong regional office with efficient, small central leadership and focused missions, an organization addresses both budgetary and mismanagement issues and sets its organizations to succeed with a narrow set of achievable, measurable, targeted goals.
Clearly, US involvement as to who caused considerable immediate uncertainty has ceased suddenly, both for the millions of patients around the world who benefited from US financial, medical and scientific support. But it can also show a new opportunity to finally fix what has broken and failed in the health of the world.
Edward Kelly is former Director of Service Delivery and Safety at the World Health Organization and Head of Global Heath. Apiject SystemInjection Technology Company. Jay Walker is the chairman of Apiject and is the founder of over 60 companies. priceline.com, And the 10th living inventor to obtain a patent.
